Free Trial

Globus Medical (GMED) Stock Price, News & Analysis

Globus Medical logo
$57.76 +0.45 (+0.79%)
Closing price 07/10/2025 03:59 PM Eastern
Extended Trading
$57.10 -0.66 (-1.14%)
As of 07/10/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Globus Medical Stock (NYSE:GMED)

Key Stats

Today's Range
$56.98
$58.44
50-Day Range
$55.54
$72.46
52-Week Range
$54.48
$94.93
Volume
972,599 shs
Average Volume
1.15 million shs
Market Capitalization
$7.82 billion
P/E Ratio
43.10
Dividend Yield
N/A
Price Target
$94.00
Consensus Rating
Moderate Buy

Company Overview

Globus Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

GMED MarketRank™: 

Globus Medical scored higher than 99% of companies evaluated by MarketBeat, and ranked 20th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Globus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.62, and is based on 8 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Globus Medical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Globus Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Globus Medical are expected to grow by 17.15% in the coming year, from $3.44 to $4.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Globus Medical is 43.10, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Globus Medical is 43.10, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.18.

  • Price to Earnings Growth Ratio

    Globus Medical has a PEG Ratio of 1.67. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Globus Medical has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Globus Medical's valuation and earnings.
  • Percentage of Shares Shorted

    4.21% of the float of Globus Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Globus Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Globus Medical has recently decreased by 10.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Globus Medical does not currently pay a dividend.

  • Dividend Growth

    Globus Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.21% of the float of Globus Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Globus Medical has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Globus Medical has recently decreased by 10.08%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Globus Medical has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Globus Medical this week, compared to 11 articles on an average week.
  • Search Interest

    Only 4 people have searched for GMED on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Globus Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Globus Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.51% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Globus Medical's insider trading history.
Receive GMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter.

GMED Stock News Headlines

Analysts Set Globus Medical, Inc. (NYSE:GMED) PT at $94.00
Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
GMED Globus Medical, Inc. - Seeking Alpha
Analysts Issue Forecasts for Globus Medical Q2 Earnings
Globus Medical: Obtaining My Backing Again
Globus Medical Q2 EPS Forecast Decreased by Zacks Research
See More Headlines

GMED Stock Analysis - Frequently Asked Questions

Globus Medical's stock was trading at $82.71 at the start of the year. Since then, GMED shares have decreased by 30.2% and is now trading at $57.76.

Globus Medical, Inc. (NYSE:GMED) released its quarterly earnings data on Thursday, May, 8th. The medical device company reported $0.68 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.74 by $0.06. The business's revenue was down 1.4% on a year-over-year basis.
Read the conference call transcript
.

Globus Medical's board approved a stock buyback plan on Thursday, May 15th 2025, which authorizes the company to repurchase $500,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 6.3% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's leadership believes its shares are undervalued.

Top institutional shareholders of Globus Medical include Swedbank AB (0.46%), Exchange Traded Concepts LLC (0.16%), TT International Asset Management LTD (0.04%) and Radnor Capital Management LLC (0.02%). Insiders that own company stock include David D Davidar, Ann D Rhoads, Leslie V Norwalk, Daniel T Scavilla, Dan Lemaitre, Keith W Pfeil and Kelly Huller.
View institutional ownership trends
.

Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW).

Company Calendar

Last Earnings
5/08/2025
Today
7/10/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:GMED
CIK
1237831
Employees
5,300
Year Founded
N/A

Price Target and Rating

High Price Target
$115.00
Low Price Target
$68.00
Potential Upside/Downside
+62.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.62
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.34
Trailing P/E Ratio
43.10
Forward P/E Ratio
16.79
P/E Growth
1.67
Net Income
$102.98 million
Net Margins
7.39%
Pretax Margin
9.28%
Return on Equity
10.52%
Return on Assets
8.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.45
Quick Ratio
2.72

Sales & Book Value

Annual Sales
$2.52 billion
Price / Sales
3.10
Cash Flow
$6.71 per share
Price / Cash Flow
8.61
Book Value
$30.40 per share
Price / Book
1.90

Miscellaneous

Outstanding Shares
135,380,000
Free Float
110,320,000
Market Cap
$7.82 billion
Optionable
Optionable
Beta
1.19

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:GMED) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners